Market Cap (In USD)
902.96 Thousand
Revenue (In USD)
18.21 Million
Net Income (In USD)
52.97 Million
Avg. Volume
1.12 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.006-0.075
- PE
- -
- EPS
- -
- Beta Value
- -0.783
- ISIN
- US30048L3024
- CUSIP
- 30048L104
- CIK
- 1618835
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Saundra Pelletier
- Employee Count
- -
- Website
- https://www.evofem.com
- Ipo Date
- 2014-11-20
- Details
- Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
More Stocks
-
AAVC
-
FBPI
-
0691
-
IMPP
-
7134
-
OXM
-
BTDPFBarratt Redrow plc
BTDPF
-
5287Ito Yogyo Co., Ltd
5287